| http://www.w3.org/ns/prov#value | - 2.3.6 In the context of a drug submissionFootnote 8, it is recommended that sponsors carry out and present an analysis to assess the influence of sex in the submission where data indicate that sex differences are a consideration, or where the product belongs to a class where sex differences are known.
|